Taprenepag (CP-544326) (CP-544326) is a potent and selective prostaglandin E2 receptor agonist (EC50 = 2.8 nM). Taprenepag has been used in trials studying the treatment of Ocular Hypertension and Glaucoma, Open-Angle.
Molecular Weight:
478.52
Purity:
98.89%
CAS Number:
[752187-80-7]
Formula:
C24H22N4O5S
Target:
Prostaglandin Receptor
T3174
* VAT and and shipping costs not included. Errors and price changes excepted